ArticleBioinformatics (Oxford, England)2026
Discovering reference-missing cell types in bulk transcriptomics.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Bulk RNA-seq deconvolution methods rely on single-cell reference data to estimate cell-type proportions in heterogeneous tissues, but certain cell types may be systematically absent from single-cell references due to technical limitations such as poor dissociation efficiency, low capture rates, or cell fragility. While recent studies have shown that signatures of missing cell types persist in deconvolution residuals, existing approaches cannot automatically determine how many cell types are missing, estimate their specific proportions, or reconstruct their expression signatures. Here, we present DeconX, a computational framework that addresses these limitations by generating "pseudo-cells" from deconvolution residuals, enabling estimation of the number, proportions, and expression signatures of missing cell types. Through comprehensive evaluation on simulated datasets, we demonstrate that DeconX accurately recovers missing cell-type proportions and expression profiles across varying conditions, and systematically identifies key factors affecting performance, including expression similarity between missing and reference cell types and missing cell-type proportions. Application to high-grade serous ovarian cancer (HGSOC) samples reasonably identifies and quantifies adipocyte populations that are absent from matched single-cell references, recovering biologically interpretable expression signatures consistent with known adipocyte markers. We further demonstrate that DeconX can reasonably determine the number of missing cell types, supporting automated analysis of unknown tissue compositions. DeconX transforms residual-based missing cell-type inference from exploratory analysis into a complete computational framework, enabling accurate characterization of tissue heterogeneity from archival bulk RNA-seq data even when single-cell references are incomplete. The source code is available at https://github.com/Seniorious123/DeconX/, and the documentation and tutorials are available at https://deconx.readthedocs.io.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.